Deadline Extended!  The internal competition deadline for a new Phase I CoBRE has been extended to December 1, 2018 for consideration of submission January 2020.  Please contact Paula Turpen in the Research Office if you have questions.

UNMC is eligible to compete for research support through the NIH NIGMS Institutional Development Award (IDeA) program. One of the principal mechanisms of IDeA support of research is the Center of Biomedical Research Excellence (COBRE) grant.

NIGMS has issued an RFA announcing new rounds of COBRE competition in 2019.  UNMC has a long-standing history of competing successfully for these $10M awards. UNMC is now eligible to submit an application for a new COBRE program.

Only one proposal may be submitted per eligible institution per fiscal year. The eligible institution is responsible for selecting and approving that project before it can be submitted.

The Office of the Vice Chancellor for Research evaluates potential UNMC proposals for COBRE grants; therefore, we are soliciting outlines of prospective projects that could be developed into full-scale COBRE proposals for the January, 2020 deadline.

Interested investigators may submit a two-page outline of their project that summarizes how they propose to address each of the CoBRE components.  The outline should follow this template format.  CoBRE Criteria  can be found here.  

These 2-page summaries are due to Deborah Hawkins (email) on December 1, 2018.

From these summaries, UNMC Deans and Directors (or their designate) will identify the project to be developed into a full COBRE proposal for submission by January, 2020.  Questions can be directed to Paula Turpen, email or 402-559-6162

Deadline: September 24, 2018

The Great Plains IDeA-CTR network is excited to announce a funding opportunity.  The grant will be awarded at the GP IDeA-CTR Annual Scientific Meeting on October 10, 2018.  Funding will be awarded to an innovative research project based on criteria delineated below. 

The goal is to raise awareness of CTR by promising scholars who are developing innovative tools and methods for medical research. The winning investigator/team will receive a pilot grant award to catalyze cutting-edge research that may translate to a sustainable product or a larger federal grant. 

We are requesting a brief research pitch (2 pages maximum) to include:  project title, principle investigator(s), participating institution(s), study aims, hypotheses, methods (brief overview of design, study sample, measures, budget and statistical analysis plan), one year deliverables, a statement addressing how the project advances CTR and a lay summary. In addition, we ask that applicants provide a biosketch for PI and all key personnel.  Download the complete RFA here.

The winner will receive up to $20,000 for one year, and access to resources of the GP IDeA-CTR to support these research efforts.  More information can be found on the GP IDeA-CTR website.

Application Deadline: October 1, 2018

Program Summary

The Otis Glebe Medical Research Foundation, which awards grants to projects focused on translational research, is now open for applications. Projects of particular interest will be those that emphasize the translation of laboratory findings to clinical practice and those that facilitate the application of research findings to the community to enhance the adoption of best practices.

Eligibility

All current UNMC faculty members are eligible to apply. Only one application per faculty member.

Award

The Glebe Foundation anticipates that it will fund one grant of up to $93,330 for a one-year period.

• Indirect costs are unallowable
• Salary for the Principal Investigator is not allowed

Application Submission Requirements

Proposals must be submitted in accordance with NIH application standards and should include:

• Face Page
• Lay Summary - avoid using scientific terms or abbreviations; the Glebe Foundation will rely heavily on this component of the application to finalize its funding decision.
• Research Plan (PHS 398 Continuation Format Page, 3/2016 revision)
  • Specific Aim(s) one page limit
  • Rationale, brief Experimental Design, and future funding plans two page limit
  • References
  • While preliminary data is not required, relevant data can be included within the two page limit
• Appendices will not be accepted
• Biosketch (NIH Biographical Sketch Format Page, 11/2016 revision)
  • Must be submitted for the Principal Investigator
  • More information on the current NIH biosketch format can be found here

Applications may be submitted to SPAdmin as a PDF emailed to spadmin@unmc.edu.

Review Process: Proposals will be submitted to an internal committee of UNMC reviewers for initial consideration. Finalists are expected to prepare and present a brief summary of their proposal to the Otis Glebe Medical Research Foundation who will make the final selection.  Funds will typically be available within one month of award notification.

Progress Report:   

A lay report of activity including any abstracts, manuscripts, patent applications, grant application or awards should be sent to SPAdmin by email no later than September 30, 2019 for later presentation to the Otis Glebe Medical Research Foundation.

Deadline

Monday, October 1, 2018……Applications due to SPAdmin no later than 5pm; a PDF may be emailed to spadmin@unmc.edu.

For more information:

• Otis Glebe Medical Research Foundation Program Guidelines (click here)
• If you have questions, please contact Holly Dunning, Coordinator, Sponsored Programs Administration, at 402-559-7458 or laura.wise@unmc.edu.

Deadline:  Monday, October 1, 2018
Funds Available:  one-year pilot projects up to $50,000-$100,000

Program Overview: The Fred & Pamela Buffett Cancer Center is accepting applications seeking support for innovative, significant pilot projects in cancer research. The purpose of the Fred & Pamela Buffett Cancer Center Pilot Projects Program is to sponsor high-quality, novel, cancer-focused research in order to foster the development of early-stage projects and encourage their transition to securing external funding.

Funding Target Areas: This is an omnibus request for applications for projects in eight target areas. 

#1 – Molecular and Biochemical Etiology of Cancer Program
#2 – Cancer Genes and Molecular Regulation Program
#3 – Gastrointestinal Cancer Program
#4 – Cancer Prevention and Control
#5 – Pediatric Cancer, in collaboration with the UNMC Pediatric Cancer Research Center 
#6 – Multiple Myeloma Program
#7 – Clinical and/or Translational Cancer Research, in collaboration with the Great Plains IDeA-CTR
#8 – SPORE in Pancreatic Cancer Developmental Research Program 

Applications can be submitted for consideration under more than one target area, if applicable.

Application Deadline: Proposals are due on Monday, October 1, 2018, by 5:00 pm CT. Applications should be submitted to Kelly Jordan. 

Additional Information: For more information, see the program Request for Applications at the link below.

FPBCC Pilot Projects Program 2018 Request for Applications 

Forms for Applicants:

FPBCC Pilot Projects Program Application Forms

Deadline: September 30, 2018

The Nebraska Center for the Prevention of Obesity Diseases (NPOD), funded by a Center for Biomedical Research Excellence grant (Award Number P20GM104320) from the NIH, invites applications for its SEED GRANT competition, pending NIH approval. This is special, one-time, funding available for projects with a required end date of May 31, 2019, with no option to obtain a no-cost extension.  The primary objective of this seed grant program is to stimulate research in the area of obesity research and nutrient signaling and to enhance competitiveness in obtaining extramural support.

 
In this call for proposals, priority will be given to proposals in two areas:    

• Area 1: Prevention of obesity-related diseases through dietary molecules. Proposals targeting this area are expected to focus on the prevention of obesity-related diseases through essential and non-essential dietary compounds. Pharmaceutical approaches to the prevention and treatment of disease will not be considered.
• Area 2: Interactions between diet and non-coding RNAs or Biomarkers of disease. Two lines of research will be considered for funding in Area 2, i.e., 1) proposals with a focus on the interactions among nutrition, non-coding RNAs, and disease, and 2) proposals with a focus on biomarkers of disease.

For more information and the application please visit https://cehs.unl.edu/seed-grant-rfa-2018/  .

Deadline:  September 28, 2018

Applications are being accepted for the Chronic HIV and Aging in NeuroAIDS (CHAIN) developmental core grant program.

The program is designed to mentor and support new investigators and new ideas in HIV/AIDS research related to effects of chronic HIV infection, co-morbidities, and aging on the central nervous system (CNS) including sex differences and viral reservoirs.

Applications are being accepted from junior investigators and from established investigators in other fields applying their expertise to HIV/AIDS. All applicants must have faculty-level appointments within the University of Nebraska system. Applications must adhere to several criteria and will undergo a rigorous, objective review process.

Developmental grant recipients gain rapid financial support for their studies and access to many CHAIN Center core resources. The success of the developmental core grant program, and continued National Institute of Mental Health funding, depends on subsequent grants and publications arising from work supported by the CHAIN Center developmental grants.

Developmental grants can be awarded for up to $50,000 for one year.

See complete instructions, guidelines, and links to forms.

This grant program is aimed at encouraging new users to employ NU core facilities in their research. The program is open to all faculty from any of the NU campuses. Awards are intended to be used to gather new or additional data for strengthening a grant proposal (new or resubmission) or for addressing reviewer concerns associated with a peer-reviewed manuscript.

Eligibility: Any faculty member (Assistant, Associate or Full Professors and equivalent-rank researchers) employed by any University of Nebraska campus is eligible to submit funding applications if they (or students/staff within their research group) have not used a specific core facility (or new technology platform within a core) during the last two fiscal years (2016-2017, 2017-2018) and who require these services to generate data to support new/resubmitted grants or resubmitted/revised manuscripts. Existing core users that request the same technologies/services from other cores (for example, standard electron microscopy on a different campus) are not considered new users.

Application Process:  Applications must be submitted electronically via grants-awards.nebraska.edu. Download RFA information, including restrictions, reporting requirements, and detailed application instructions here.

Amount: The maximum request is $5,000 per core facility and a total of $9,000 per new user if more than one core facility is to be used. 

Deadline: Proposals will be reviewed quarterly during the first 3 quarters of the fiscal year (July/August, October/November, and January/February). Please allow 2 – 3 weeks for review and decision on the proposal. Note that funds must be used by June 30, 2019; no new award will be made after March 31, 2019. 

For more information about the campus cores on any campus or applications for this program, please contact your campus' research office.  (UNMC: Paula Turpen, email or 402-559-6162)

The Buffett Cancer Center is pleased to announce a new FPBCC bridge funding program intended to support the research of Cancer Center members who have received encouraging scores that fell below the funding threshold on recent cancer-focused grant applications. The purpose of this program is to support the efforts necessary to produce additional data for promising cancer research projects, in order to strengthen related proposal resubmissions to federal funding agencies. 

The Buffett Cancer Center is primarily seeking to support proposals submitted after February 2017 that fit within the following criteria:

• New (A0) applications that received priority scores outside of the granting agency's current pay line; or
• Grants that have been submitted for competitive renewal and received a competitive but non-fundable score within two years from the expiration of the current award.

Eligibility for bridge funding extends to all Fred & Pamela Buffett Cancer Center Members who are applying for or renewing individual investigator awards, multi-investigator awards, center grants, and program project grants from federal funding agencies and/or nationally peer-reviewed organizations. Funding priority will be given to those who submitted applications to the NCI, followed by those with cancer-focused proposals submitted to other NIH institutes or other federal agencies. 

To be considered for this opportunity, please review the request for applications available at: https://unmc.edu/cancercenter/research/research-funding-opp.html. Applications must be prepared in accordance with the guidelines outlined in the RFA and submitted as a single, complete PDF to both Matt Winfrey (winfreym@unmc.edu) and Kelly Jordan (kjordan@unmc.edu). Proposals requesting bridge funding will be accepted on a rolling basis.

Catalog of DoD Funding Opportunities

The Online Partnership to Accelerate Research (OnPAR) was conceived to re-accelerate the biomedical research and development enterprise by seeking a larger return on NIH's peer review investment on research proposals evaluated in the top 30% in each NIH Institute and Center.  The goal of OnPAR is to match quality biomedical research projects with priority areas of interest of private foundations, and pharmaceutical and biotech companies and/or other private biomedical research funders.

How to Apply

Leidos has worked with NIH Program Officers to inform applicant Principal Investigators that have scored well, but below the Institute/Center payline, about OnPAR. If an applicant scored in the top 30% and is not funded by NIH, he/she is welcome to submit an abstract for consideration. Qualified applicants are invited to register with OnPAR and participate in the submission and review process. It is not necessary to re-write an application. OnPAR will accept the NIH abstract that was submitted by the applicant, and if invited, his/her submitted NIH application and Summary Statement.

Read more about the application process and register for OnPAR